CN100339014C - Application of N-acetylglucosamine in dairy product and dairy product containing N-acetylglucosamine - Google Patents
Application of N-acetylglucosamine in dairy product and dairy product containing N-acetylglucosamine Download PDFInfo
- Publication number
- CN100339014C CN100339014C CNB031082742A CN03108274A CN100339014C CN 100339014 C CN100339014 C CN 100339014C CN B031082742 A CNB031082742 A CN B031082742A CN 03108274 A CN03108274 A CN 03108274A CN 100339014 C CN100339014 C CN 100339014C
- Authority
- CN
- China
- Prior art keywords
- dairy products
- acetylglucosamine
- test
- acceptable salt
- dairy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了N-乙酰氨基葡萄糖作为添加剂在乳制品中的应用,及包含N-乙酰氨基葡萄糖的新型乳制品。所述新型乳制品产生了新的对机体有益的效果,在人群试用中效果显著。The invention discloses the application of N-acetylglucosamine as an additive in dairy products and a novel dairy product containing N-acetylglucosamine. The new dairy product produces new beneficial effects on the body, and the effect is remarkable in crowd trials.
Description
技术领域Technical field
本发明涉及N-乙酰氨基葡萄糖或其乳制品可接受的盐作为添加剂在乳制品中的应用,及包含N-乙酰氨基葡萄糖或其乳制品可接受的盐的乳制品。The present invention relates to the application of N-acetylglucosamine or its acceptable salt for dairy products as an additive in dairy products, and dairy products containing N-acetylglucosamine or its acceptable salt for dairy products.
背景技术 Background technique
乳品营养成份丰富,应用广泛,与人类生存密切相关,成为营养学研究的主要对象。生物学新理论的形成自然也联系到乳制品。生物波理论是生物学的新理论,是在当代物理数学领域的最新进展—复杂性探索基础上,结合生物学和医学的实际情况,通过试验研究确立、证实的最新生物学理论(参见,《生物波理论的研究》,中国微生态学杂志,1994,6(6):40-49)。生物波理论认为人体是一个开放系统,代谢过程促成生物耗散与生态统一,执行着生命活动功能。将生物波理论应用于营养学中,提出了营养物质利用的条件决定观点,即生物波调控因子促进营养的吸收和利用。Dairy products are rich in nutrients, widely used, closely related to human survival, and become the main object of nutrition research. The formation of new biological theories is naturally also related to dairy products. Biological wave theory is a new theory of biology. It is the latest biological theory established and confirmed through experimental research on the basis of the latest progress in the field of contemporary physics and mathematics—complexity exploration, combined with the actual situation of biology and medicine (see, " Research on Biological Wave Theory", Chinese Journal of Microecology, 1994, 6(6): 40-49). The biological wave theory believes that the human body is an open system, and the metabolic process promotes biological dissipation and ecological unity, and performs the functions of life activities. Applying the biological wave theory to nutrition, the point of view that the condition of nutrient utilization is determined, that is, biological wave regulation factors promote the absorption and utilization of nutrients.
FR2101030公开了一种复合物,包含猪胃粘蛋白水解物和15%w/w的N-乙酰基-D-氨基葡萄糖。该复合物是双叉乳杆菌(Lactobacillus Bifidus)的生长因子,用作喂食牛奶的婴儿的膳食补充物,从而提供具有与人乳效果相似的膳食,并建立正常的肠内菌丛。FR2101030 discloses a complex comprising porcine gastric mucin hydrolyzate and 15% w/w N-acetyl-D-glucosamine. The complex is a growth factor of Lactobacillus Bifidus and is used as a dietary supplement for infants fed cow's milk, thus providing a diet with effects similar to human milk and establishing a normal intestinal flora.
本发明人经过研究惊异地发现,N-乙酰氨基葡萄糖或其乳制品可接受的盐用作乳制品添加剂制备成的新型乳制品,与传统的乳制品相比,具有吸收快、效果好的特点。After research, the present inventor surprisingly found that N-acetylglucosamine or its milk product acceptable salt is used as a new type of dairy product prepared as a dairy product additive. Compared with traditional dairy products, it has the characteristics of fast absorption and good effect .
发明内容Contents of the invention
本发明的一个目的是提供N-乙酰氨基葡萄糖或其乳制品可接受的盐作为添加剂在乳制品中的应用。One object of the present invention is to provide the application of N-acetylglucosamine or its acceptable salt for dairy products as an additive in dairy products.
本发明的另一个目的是提供包含N-乙酰氨基葡萄糖或其乳制品可接受的盐的乳制品。Another object of the present invention is to provide a dairy product comprising N-acetylglucosamine or a dairy acceptable salt thereof.
本发明的又一个目的是提供一种制备乳制品的方法,包括向原料乳制品中加入N-乙酰氨基葡萄糖或其乳制品可接受的盐的步骤。Another object of the present invention is to provide a method for preparing dairy products, which includes the step of adding N-acetylglucosamine or a dairy acceptable salt thereof to raw milk products.
所述的N-乙酰氨基葡萄糖全名为N-乙酰基-D-氨基葡萄糖(N-acetyl-D-glucosamine),分子式为C8H15NO6,结构式(I)表示如下:The full name of the N-acetylglucosamine is N-acetyl-D-glucosamine (N-acetyl-D-glucosamine), the molecular formula is C 8 H 15 NO 6 , and the structural formula (I) is as follows:
可用于本发明的N-乙酰基-D-氨基葡萄糖乳制品可接受的盐的实例包括但不限于:与无机酸形成的那些盐,如盐酸盐、磷酸盐、磷酸氢盐,以及与有机酸形成的那些盐,如柠檬酸盐、苯甲酸盐、抗坏血酸盐。Examples of dairy-acceptable salts of N-acetyl-D-glucosamine that may be used in the present invention include, but are not limited to, those salts with inorganic acids, such as hydrochloride, phosphate, hydrogen phosphate, and those with organic acids. Those salts formed by acids such as citrate, benzoate, ascorbate.
对可用于本发明的乳品原料和本发明的成品乳制品实际上没有任何限制。本发明的乳制品可以是人们生活中通常食用的任何形式的乳制品,例如,可以是液态如液体奶;固态如奶粉、干酪;半固态如酸奶、冰激凌等。所述乳制品可以是普通乳制品,也可以是各种营养强化乳制品如加钙奶等。There is virtually no restriction on the dairy raw materials that can be used in the present invention and the finished dairy products of the present invention. The dairy product of the present invention can be any form of dairy product that people usually eat in life, for example, it can be liquid such as liquid milk; solid such as milk powder and cheese; semi-solid such as yogurt and ice cream. The dairy products can be ordinary dairy products, or various nutritionally fortified dairy products such as calcium-added milk and the like.
对N-乙酰基-D-氨基葡萄糖或其乳制品可接受的盐在乳品中的加入方式实际上也没有任何限制,只要所述加入方式对N-乙酰基-D-氨基葡萄糖或其乳制品可接受的盐和乳品中的其它有效成分无不利影响。There is also virtually no restriction on the way in which N-acetyl-D-glucosamine or its dairy product-acceptable salts can be added to dairy products, as long as the method of addition is effective for N-acetyl-D-glucosamine or its dairy products. Acceptable salts and other active ingredients in dairy products have no adverse effects.
在本发明的一个实施方案中,所述N-乙酰基-D-氨基葡萄糖或其乳制品可接受的盐可以以粉末形式加入到奶粉中。In one embodiment of the present invention, the N-acetyl-D-glucosamine or a dairy acceptable salt thereof can be added to milk powder in the form of powder.
在本发明的另一个实施方案中,所述N-乙酰基-D-氨基葡萄糖或其乳制品可接受的盐可以加入到液态乳品中,然后该乳品就这样进行销售,或进一步采用本领域公知的技术制备成例如奶粉、酸奶等。In another embodiment of the present invention, the N-acetyl-D-glucosamine or its acceptable salt for dairy products can be added to the liquid milk, and then the milk is sold as it is, or further adopt known methods in the art. Prepared with advanced technology such as milk powder, yogurt, etc.
N-乙酰氨基葡萄糖或其乳制品可接受的盐在乳制品中的含量一般为0.001g/100ml至10g/100ml。优选为0.01g/100ml至2g/100ml。以乳制品中的固体有效物质的重量计,N-乙酰氨基葡萄糖或其乳制品可接受的盐在乳制品中的含量一般为0.1-10%,优选0.1-2%。The content of N-acetylglucosamine or its acceptable salt for dairy products in dairy products is generally 0.001g/100ml to 10g/100ml. Preferably it is 0.01 g/100ml to 2g/100ml. Based on the weight of solid effective substances in dairy products, the content of N-acetylglucosamine or acceptable salts thereof in dairy products is generally 0.1-10%, preferably 0.1-2%.
本发明的包含N-乙酰氨基葡萄糖或其乳制品可接受的盐的新型乳制品产生了新的对机体有益的效果,在人群试用中效果显著。The novel dairy product containing N-acetylglucosamine or its acceptable salt for dairy products of the present invention has a new beneficial effect on the body, and the effect is remarkable in crowd trials.
具体实施方式Detailed ways
下面结合实施例进一步说明本发明及其有益效果,但是应该明白,这些实施例仅是为了举例说明本发明,而不在任何方面构成对本发明范围的限制。The present invention and its beneficial effects will be further described below in conjunction with the examples, but it should be understood that these examples are only for illustrating the present invention, and are not intended to limit the scope of the present invention in any way.
实施例1.式(I)化合物的促波试验Embodiment 1. The wave-promoting test of the compound of formula (I)
1、试验材料和方法:1. Test materials and methods:
1.1样品:式(I)化合物纯品。1.1 Sample: pure compound of formula (I).
1.2试验材料:1.2 Test material:
菌种:奇异变形杆菌应符合如下生化反应特征:动力(+)、尿素酶(+)、乳糖(-)、葡萄糖(+)、H2S(-)、苯丙氨酸脱氨酶(+)。Strains: Proteus mirabilis should meet the following biochemical reaction characteristics: motility (+), urease (+), lactose (-), glucose (+), H 2 S (-), phenylalanine deaminase (+ ).
培养基:改良LB培养基(组成成分:1%胰蛋白胨、0.5%酵母提取物、1%氯化钠、0.1%葡萄糖、0.002%TTC、PH7.2-7.4)。Medium: modified LB medium (composition: 1% tryptone, 0.5% yeast extract, 1% sodium chloride, 0.1% glucose, 0.002% TTC, pH7.2-7.4).
1.3试验方法:1.3 Test method:
对照样:在LB平板中心点种奇异变形杆菌,37℃培养9小时;Control sample: plant Proteus mirabilis in the center of the LB plate and culture at 37°C for 9 hours;
试验样:在LB平板中加入终浓度为0.5%的式(I)化合物,同法点种奇异变形杆菌,37℃培养9小时。Test sample: Add the compound of formula (I) at a final concentration of 0.5% to the LB plate, plant Proteus mirabilis in the same way, and culture at 37° C. for 9 hours.
2、试验结果及评价:2. Test results and evaluation:
在对照样中显示出不断向外扩展,间隔3小时的同心环;在试验样中,不但形成每隔3小时出现的同心环,而且与对照相比,在每条环上显示出许多细小的波动环。In the control sample, there are concentric rings that continuously expand outwards at intervals of 3 hours; in the test sample, not only the concentric rings that appear every 3 hours are formed, but also many small rings are displayed on each ring compared with the control sample. Volatility ring.
本试验采用生物波波动试验模型,用以研究式(I)化合物的促波作用,结果可见式(I)化合物不仅可以使细菌细胞表现正常的生物波特征,而且使这种波动表现出更加微细的波动方式,表明式(I)化合物对生物波动是有促进作用的。式(I)化合物的这种促波作用有助于解释N-乙酰氨基葡萄糖促进乳制品有效成分吸收的效果。This test adopts the biological wave fluctuation test model to study the wave-promoting effect of the compound of formula (I). The results show that the compound of formula (I) can not only make the bacterial cells exhibit normal biological wave characteristics, but also make this fluctuation show more subtle Fluctuation mode, shows that the compound of formula (I) has promoting effect to biological fluctuation. The wave-promoting effect of the compound of formula (I) helps to explain the effect of N-acetylglucosamine on promoting the absorption of active ingredients in dairy products.
实施例2.式(I)化合物的毒理试验The toxicological test of embodiment 2. formula (I) compound
进行式(I)化合物的毒理试验,包括:Carry out the toxicology test of formula (I) compound, comprise:
1、急性毒理试验:包括口服、静脉注射和最大极限量给药试验;1. Acute toxicology test: including oral, intravenous injection and maximum dose administration test;
2、Ames试验;2. Ames test;
3、小鼠骨髓细胞微核试验;3. Mouse bone marrow cell micronucleus test;
4、鼠精子畸性试验;4. Mouse sperm teratogenic test;
5、小鼠睾丸染色体畸变试验;5. Chromosomal aberration test of mouse testis;
6、慢性致死试验;6. Chronic lethal test;
7、亚慢性毒性(90天喂养)试验;7. Subchronic toxicity (90-day feeding) test;
8、传统致畸试验;8. Traditional teratogenicity test;
试验结论表明:式(I)化合物急性毒性试验剂量超过2g/kg时,仍未出现急性中毒反应;在长期毒性试验中,最高剂量已达到1g/kg,经四周试验观察,未出现中毒反应;在生殖试验中,从常规剂量7mg/kg喂小鼠,经三次传代,证明式(I)化合物对小鼠受孕、妊娠、分娩、哺乳及仔鼠发育均无影响。这些试验证明式(I)化合物属无毒物质。Test conclusion shows: when formula (I) compound acute toxicity test dose exceeds 2g/kg, acute poisoning reaction does not yet occur; In long-term toxicity test, the highest dose has reached 1g/kg, through four weeks test observation, no toxic reaction occurs; In the reproduction test, mice were fed from a conventional dose of 7 mg/kg, and after three passages, it was proved that the compound of formula (I) had no effect on the conception, pregnancy, childbirth, lactation and development of offspring of mice. These tests demonstrate that the compound of formula (I) is a non-toxic substance.
实施例3.动物试验Embodiment 3. Animal test
(1)增加食欲(1) increase appetite
采用昆明种小鼠进行试验。对照组口服灌胃牛奶,试验组牛奶中加入N-乙酰氨基葡萄糖(加入量:0.1g/100ml牛奶),结果观察到试验组小鼠觅食周期缩短,更多食物粉碎(代表动物觅食活跃),进食量增大,体重明显增加。Kunming mice were used for the experiment. The control group was orally gavaged with milk, and N-acetylglucosamine (addition amount: 0.1g/100ml milk) was added to the milk of the test group. As a result, it was observed that the foraging cycle of the mice in the test group was shortened, and more food was crushed (representing that the animals were actively foraging). ), increased food intake, and significantly increased body weight.
(2)促进乳鼠发育(2) Promote the development of suckling mice
采用昆明种小鼠进行试验,先取孕期母鼠,分为试验组和对照组。试验组口服灌胃本发明乳制品(市售奶粉中加入N-乙酰氨基葡萄糖0.1g/100g奶粉),对照组口服灌胃市售奶粉,一直喂养直至乳鼠出生哺乳15天,称量两组仔代小鼠的平均体重,试验组明显高于对照组。The Kunming mice were used for the experiment, and the pregnant female mice were firstly taken and divided into a test group and a control group. The test group was orally gavaged the dairy product of the present invention (in the commercially available milk powder, N-acetylglucosamine 0.1g/100g milk powder was added), and the control group was orally gavaged with the commercially available milk powder, and were fed until the suckling mice were born and suckled for 15 days, and the two groups were weighed. The average body weight of offspring mice was significantly higher in the experimental group than in the control group.
实施例4.初步人群试用试验Example 4. Preliminary population trial trial
36名自愿者人群试验表明,与饮用一般牛奶相比,饮用本发明乳制品(灭菌鲜奶中加入N-乙酰氨基葡萄糖0.1g/100ml)者反映食欲增加,胃口好,特别是有胃肠疾病时,效果更加明显,饮用后自觉体力恢复快,行动有力,精神状态好,有效率达90%以上。36 voluntary population experiments showed that compared with drinking ordinary milk, those who drank the dairy product of the present invention (adding N-acetylglucosamine 0.1g/100ml in the sterilized fresh milk) reported increased appetite and good appetite, especially those with gastrointestinal When you are sick, the effect is more obvious. After drinking, you feel that your physical strength will recover quickly, your actions will be strong, and your mental state will be good. The effective rate is over 90%.
实施例5.本发明乳制品的制备实施例Embodiment 5. the preparation embodiment of dairy product of the present invention
1.以固体形式将N-乙酰氨基葡萄糖加入到牛奶中,制成N-乙酰氨基葡萄糖含量为0.1g/100ml的液体奶。1. Add N-acetylglucosamine into milk in solid form to prepare liquid milk with an N-acetylglucosamine content of 0.1g/100ml.
2.以固体形式将N-乙酰氨基葡萄糖盐酸盐加入到牛奶中,制成N-乙酰氨基葡萄糖含量为0.1g/100ml的液体奶。2. Add N-acetylglucosamine hydrochloride in solid form to milk to prepare liquid milk with an N-acetylglucosamine content of 0.1 g/100ml.
3.以固体形式将N-乙酰氨基葡萄糖加入到奶粉中,制成N-乙酰氨基葡萄糖含量为0.2g/100g的固体奶粉。3. Adding N-acetylglucosamine into milk powder in solid form to prepare solid milk powder with an N-acetylglucosamine content of 0.2 g/100 g.
4.以固体形式将N-乙酰氨基葡萄糖加入到发酵后的酸奶中,制成N-乙酰氨基葡萄糖含量为0.1g/100ml的酸奶。4. Adding N-acetylglucosamine in solid form to the fermented yogurt to prepare yogurt with an N-acetylglucosamine content of 0.1 g/100ml.
5.以10%重量水溶液的形式将N-乙酰氨基葡萄糖柠檬酸盐加入到牛奶中,制成N-乙酰氨基葡萄糖最终含量为0.1g/100ml的液体奶。5. Add N-acetylglucosamine citrate into milk in the form of 10% by weight aqueous solution to prepare liquid milk with a final content of N-acetylglucosamine of 0.1 g/100 ml.
对上述乳制品的观察发现,加入N-乙酰氨基葡萄糖或其盐未对乳制品的外观产生明显影响。The observation of the above dairy products found that the addition of N-acetylglucosamine or its salt did not have a significant impact on the appearance of the dairy products.
Claims (7)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031082742A CN100339014C (en) | 2003-03-27 | 2003-03-27 | Application of N-acetylglucosamine in dairy product and dairy product containing N-acetylglucosamine |
| PCT/CN2004/000279 WO2004093556A1 (en) | 2003-03-27 | 2004-03-29 | The use of n-acetyl glucosamine as additive in milk products |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031082742A CN100339014C (en) | 2003-03-27 | 2003-03-27 | Application of N-acetylglucosamine in dairy product and dairy product containing N-acetylglucosamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1533700A CN1533700A (en) | 2004-10-06 |
| CN100339014C true CN100339014C (en) | 2007-09-26 |
Family
ID=33304435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031082742A Expired - Fee Related CN100339014C (en) | 2003-03-27 | 2003-03-27 | Application of N-acetylglucosamine in dairy product and dairy product containing N-acetylglucosamine |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN100339014C (en) |
| WO (1) | WO2004093556A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2918376B1 (en) | 2007-07-04 | 2011-10-28 | Mathieu Borge | LIQUID OR PASSIZED COMPOSITIONS FOR THE CONTRIBUTION OF ESSENTIAL ELEMENTS TO THE SYNTHESIS AND CONSTITUTION OF PROTEOGLYCANS, IN PARTICULAR FOR THE TREATMENT OF CARTILAGE DEGRADATION |
| CN106072653A (en) * | 2015-05-02 | 2016-11-09 | 邓渝 | The vegetable protein beverage of 2-Acetamido-2-deoxy-D-glucose and application thereof |
| CN106333314A (en) * | 2015-07-09 | 2017-01-18 | 邓渝 | Application of N-acetylglucosamine to honey product and honey product containing N-acetylglucosamine |
| CN110367335A (en) * | 2019-08-30 | 2019-10-25 | 江西阳光乳业股份有限公司 | A kind of preparation method of health Yoghourt |
| CN120226697B (en) * | 2025-06-03 | 2025-08-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Liquid dairy product for improving bone and joint health and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1519555A (en) * | 1966-07-26 | 1968-04-05 | Expl Des Etablissements Larous | Dietetic product for weaned infants |
| FR2101030A1 (en) * | 1970-08-11 | 1972-03-31 | Sogeras | New biogical bifidogene complex - useful as infant diet supplement |
| CN1227495A (en) * | 1996-08-09 | 1999-09-01 | 曼纳泰克公司 | Compositions of plant carbohydrates as dietary supplements |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3677949A (en) * | 1970-09-04 | 1972-07-18 | Enthone | Selectively stripping tin and/or lead from copper substrates |
| CN1095366C (en) * | 1996-12-27 | 2002-12-04 | 中国人民解放军第三军医大学 | Application of N-aceto-D-aminoglucose in medicinal preparation for curing intestinal diseases |
| WO2003012074A2 (en) * | 2001-07-30 | 2003-02-13 | Den Kgl. Veterinær- Og Landbohøjskole | Bacterial strains belonging to lactobacillus species and their use in food and feed industry |
-
2003
- 2003-03-27 CN CNB031082742A patent/CN100339014C/en not_active Expired - Fee Related
-
2004
- 2004-03-29 WO PCT/CN2004/000279 patent/WO2004093556A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1519555A (en) * | 1966-07-26 | 1968-04-05 | Expl Des Etablissements Larous | Dietetic product for weaned infants |
| FR2101030A1 (en) * | 1970-08-11 | 1972-03-31 | Sogeras | New biogical bifidogene complex - useful as infant diet supplement |
| CN1227495A (en) * | 1996-08-09 | 1999-09-01 | 曼纳泰克公司 | Compositions of plant carbohydrates as dietary supplements |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1533700A (en) | 2004-10-06 |
| WO2004093556A1 (en) | 2004-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102399733B (en) | Lactobacillus johnsonii, microbial inoculum, application and premix thereof | |
| CA2436752C (en) | Bifidobacteria and preparations containing them | |
| EP2754354B1 (en) | Method for using a bacillus subtilis strain to enhance animal health | |
| CN1283171C (en) | Selenium-rich probiotics foder additive production method and its product | |
| JP2019506856A5 (en) | ||
| CN103098986B (en) | Beneficial microorganism antibiont-free feed and preparation method thereof | |
| CN1843385A (en) | Enteral microecological formulation and its preparation process | |
| KR20120031522A (en) | Fermentation and culture method, fermented plant extract, fermented plant extract powder and composition containing the fermented plant extract | |
| CN112716983B (en) | Use of Lactobacillus reuteri strain GKR1 for preparing a composition for reducing uric acid | |
| CN101912046B (en) | Porcine lactobacillus plantarum microcapsules and application thereof | |
| CN102524539B (en) | Animal health preserver composition and preparation process for animal health preserver composition | |
| CN101229196B (en) | Microecologic agent preventing grice diarrhoea and preparing method thereof | |
| CN100558883C (en) | New strains of the genus Bifidobacterium with the ability to produce glutamine | |
| CN100339014C (en) | Application of N-acetylglucosamine in dairy product and dairy product containing N-acetylglucosamine | |
| JP2008013534A (en) | Probiotics product for pet animal | |
| CN1305383C (en) | Active bifidobacteria contained milk powder and its preparation method | |
| CN106819470A (en) | Pig feed additive and its preparation method and application | |
| CN1066917C (en) | Milk product enriched with ground eggshell | |
| CN112322531A (en) | Production method and application of high-activity lactobacillus acidophilus freeze-dried powder | |
| CN114304611B (en) | Water-soluble composite nutrients and production method thereof | |
| CN115747106B (en) | Composite probiotic agent for degrading cat hair, degradation method, and preparation method of freeze-dried cat snacks | |
| RU2147183C1 (en) | Fermented-milk dried product "narine" | |
| JP5072286B2 (en) | Animal immunomodulator | |
| RU2173159C2 (en) | Method of production of biologically active food addition | |
| CN118667718B (en) | A kind of Lactobacillus plantarum HP-ZW2 and its application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: SUZHOU CITY BAWEI CHINESE MEDICINE DEVELOPMENT RE Effective date: 20050422 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20050422 Address after: Chongqing city Shapingba street 400038 gaotanyan No. 30 Applicant after: Third Military Medical University, Chinese People's Liberation Army Co-applicant after: Suzhou Bawei Medicine Development Research Institute Co., Ltd. Co-applicant after: Beijing Hong Kong Fu biological wave Technology Co. Ltd. Address before: Chongqing city Shapingba street 400038 gaotanyan No. 30 Applicant before: Third Military Medical University, Chinese People's Liberation Army |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070926 Termination date: 20120327 |